Template 9: Ask Anything • Innova Captab Case Study • GICS Peer Override
Following along? Install the extension first
Finmagine AI Advisor — free • no account needed • Chrome, Edge, Brave
Finmagine AI Advisor v2.8.0 ships two independent upgrades. They solve different problems, but both come from the same root cause: Screener.in is a data platform, not an answer platform. It shows you tables and documents. It does not answer your questions.
You are looking at Innova Captab. Management mentioned their Jammu facility ramp-up in every concall for the last three quarters. You want the numbers: what is the revenue contribution from Jammu, how much capex has been invested, what is the optimal capacity and timeline? All of this is in the concall transcripts.
But Screener.in gives you a list of 12 PDF links. Not answers. You would need to open each PDF, search for relevant passages, cross-reference across quarters, reconcile different numbers. That is 45 minutes of document work before you can think about the investment question.
Screener.in auto-detects peer companies using GICS sector codes. For large-cap sectors with clean sub-industry definitions — IT Services, Private Banking, FMCG — this works well. TCS gets Infosys and Wipro. HDFC Bank gets ICICI Bank and Kotak.
But for mid-cap and specialized sub-sectors, GICS granularity breaks down. Innova Captab is a pharma contract development and manufacturing organization (CDMO). It gets grouped with Divi's Laboratories and Cipla — an API manufacturer and a branded generic company respectively. Neither is a CDMO. Comparing Innova Captab's margins and capital intensity to Divi's or Cipla produces a misleading peer analysis. The right peers are Akums Drugs and Windlas Biotech.
AKUMS, WINDLAS and the analysis runs on the right peers.
| Feature | Problem Solved | Template | Best AI |
|---|---|---|---|
| Ask Anything (AMA) NEW | Manual PDF searching across 12+ concalls and annual reports | Template 9 (India) | Claude |
| Manual Peer Selection NEW | GICS-based wrong peer groupings from Screener.in | Template 7 (Peer Comparison) | Claude / ChatGPT |
When NotebookLM launched, users immediately grasped its core insight: upload documents, ask questions, get citations. It became the go-to tool for reading long PDFs efficiently. The same need exists for Indian stock research. Every investor with a Screener.in premium account has access to a company's complete document library. What was missing was a structured way to ask questions against that library from within the same research workflow.
"Works like NotebookLM — reads all annual reports and concalls, answers with citations."
That is the design requirement for Ask Anything. The extension already has access to all document URLs for every company through the Finmagine Data Layer. v2.8.0 bundles those URLs into a targeted Q&A prompt with strict citation-only instructions and sends it to Claude.
When you open the Ask Anything template on any Screener.in company page, the extension shows:
"What did management say about capacity expansion plans in the last 3 concalls?"
"What are the main risks mentioned in the latest annual report?"
"How has working capital trend changed over the last 3 years according to management?"
"What regulatory approvals has the company received or applied for recently?"
"What is management's guidance for revenue and margins for the next 2 years?"
The prompt instructs Claude to respond exclusively in a structured citation format. No narrative paragraphs, no synthesis, no generic observations — only numbered FINDING blocks. Each block has exactly two fields: Source (the document name and period) and Finding (one specific factual point with exact numbers or direct quotes).
Gemini Deep Research is designed to produce comprehensive research reports. That design goal conflicts directly with the Ask Anything use case. Gemini Deep Research will receive the AMA prompt, recognize it as a research question about a company, and produce a full multi-section report regardless of format instructions. It ignores the FINDING structure because its training objective is comprehensive coverage, not targeted Q&A.
Claude is trained to follow structured output instructions. When the AMA prompt says "respond only in FINDING blocks, one fact per finding," Claude complies. The output is a clean numbered list of citations — exactly what makes the template useful for rapid document research.
For this reason, the Ask Anything template card in the extension UI shows: ✦ Best with: Claude. All other templates retain their existing BEST_WITH recommendations.
To demonstrate Ask Anything with a real example, we ran the template on Innova Captab (NSE: INNOCAP) with the following question:
"What did management say about capacity expansion plans in the last 3 concalls?"
Claude read the Q1 FY26, Q2 FY26, and Q3 FY26 concall transcripts and returned 11 FINDING blocks in under 2 minutes. Here is the complete output:
Eleven findings, all citation-backed, all traceable to a specific quarter. No hallucinations — every number matches what management actually stated. The exact revenue progression (₹60 Cr in Q2 → ₹89 Cr in Q3), the capex figure (₹480 Cr+), the revenue potential (₹1,400 Cr+ at 65–70% utilization), and the revised guidance (₹270–280 Cr from ₹400 Cr) are all direct citations, not AI-constructed summaries.
Screener.in auto-detects peers from the Peers table on each company page. The grouping algorithm uses GICS (Global Industry Classification Standard) sector codes. At the broad sector level — Information Technology, Consumer Staples, Financials — GICS is accurate. But at the sub-industry level, GICS has known blind spots for Indian mid-cap companies with specialized business models.
A pharma CDMO (Innova Captab), a pharma API manufacturer (Divi's Laboratories), and a branded generic company (Cipla) can share the same GICS sub-industry code. Their business models are completely different: CDMO revenues are contract-based with lower volatility; API revenues track commodity chemical cycles; branded generic revenues depend on prescription volume and pricing power. Comparing margins, asset turns, and capital intensity across these three as "peers" produces misleading conclusions.
The Peer Comparison template auto-detected all peers from Screener's Peers table, immediately initiated data fetches from the Finmagine Data Layer for each peer, and showed a status panel. There was no way to override the peer list.
The Peer Comparison template now has a two-step flow. Step 1 is always shown before any data fetch:
Auto-detected from Screener.in — uncheck any that are not relevant comparators:
If custom codes are provided, they replace the auto-detected list entirely.
Once you click "Analyze These Peers," the template proceeds to Step 2 — the same status panel as in previous versions, showing data fetch progress for each selected peer. A small "✐ Edit peers" button in the step 2 header lets you go back and change your selection without starting over.
Innova Captab: deselect Divi's / Cipla, add AKUMS, WINDLAS. Now comparing CDMO to CDMO on contract revenue mix, utilization rates, and regulated vs domestic market split.
Mid-cap specialty chem: keep 2 of 6 auto-detected peers that are true specialty players, add NOCIL as a more relevant comparator. Removes commodity chemical noise from the analysis.
Recently listed company: Screener auto-detects wrong peers because the stock has been live for less than one full reporting cycle. Override entirely with manually researched NSE codes.
The four AI platforms supported by Finmagine AI Advisor have different design goals. Understanding which platform fits which template type makes a material difference in output quality.
| AI Platform | Design Goal | Best Templates | AMA Suitability |
|---|---|---|---|
| Gemini Deep Research | Comprehensive reports with web grounding | Comprehensive, Management Quality, Deep Research, Forensic Governance | Poor — ignores format constraints, always produces a full research report |
| Claude | Instruction-following, structured output | Ask Anything, Investor Panel, Risk-Reward, Peer Comparison | Excellent — follows FINDING format precisely, one fact per block |
| ChatGPT | General-purpose analysis | Quarterly, Risk-Reward, Peer Comparison | Moderate — may add narrative bridges between findings |
| Perplexity | Real-time web search + citations | Quick lookups, current events context | Moderate — useful if BSE PDFs are inaccessible, uses web fallback |
Gemini Deep Research's training objective is to produce comprehensive coverage of a topic, not to follow a narrowly constrained output format. Even with explicit format instructions, it interprets the AMA prompt as a research question and produces a full multi-section report. This is by design — it is the right tool for Comprehensive Analysis and Forensic Governance. It is the wrong tool for targeted Q&A with atomic citations.
Claude follows structured output instructions faithfully because instruction adherence is a core capability it is explicitly trained for. The FINDING/Source/Finding format constraint is preserved across all 11+ findings in the Innova Captab output above — Claude never drifts into narrative even for complex multi-quarter questions.
With v2.8.0, Finmagine AI Advisor has 13 analysis templates in total — 9 for Indian stocks on Screener.in and 4 for US/Global stocks on stockanalysis.com.
| # | Template | Focus | Best AI |
|---|---|---|---|
| 1 | Comprehensive Analysis | 360° Five-Parameter assessment + unit economics | Gemini Deep Research |
| 2 | Risk-Reward Analysis | Bull / base / bear scenarios, downside protection | Claude / ChatGPT |
| 3 | Management Quality | Capital allocation, governance, concall intelligence | Gemini Deep Research |
| 4 | Quarterly Deep-Dive | Latest quarter trends, near-term outlook | Claude / ChatGPT |
| 5 | Deep Research | 9-part forensic with PDF document reading | Gemini Deep Research |
| 6 | Forensic Governance | RPTs, pledging, earnings call language, CARO | Gemini / Claude |
| 7 | Peer Comparison | Auto-fetched sector peer data, 4-analyst scorecard + Manual Peer Selection | Claude / ChatGPT |
| 8 | Investor Panel | 6 legendary investors debate the stock independently | Claude / ChatGPT |
| 9 | Ask Anything (AMA) NEW | Type any question, Claude answers with FINDING citations from all concalls and annual reports | Claude |
| # | Template | Focus |
|---|---|---|
| 1 | Forensic Analysis | Z-Score, F-Score, ROIC-WACC, governance |
| 2 | Comprehensive Analysis | 360° US company assessment |
| 3 | Risk-Reward Analysis | Scenario analysis for US stocks |
| 4 | Quarterly Deep-Dive | Latest quarter + earnings context |
Click any card to reveal the answer. Use the search box to find specific topics. Covers Ask Anything, Manual Peer Selection, the FINDING format, and the Innova Captab case study.
Free Chrome Extension
Install the Finmagine AI Advisor and generate institutional-grade research prompts from any Screener.in or stockanalysis.com company page in seconds.
Install from Chrome Web Store →No account required • Works on Chrome, Edge, Brave, Opera
9 India templates + 4 US templates — including Ask Anything, Investor Panel, Forensic Governance, and Peer Comparison — with sector-aware intelligence, health scoring, and full document library Q&A.
Visit AI Advisor Hub →